• Mashup Score: 2

    A groundbreaking, BCRF-supported phase III clinical trial, RxPONDER, has just demonstrated that some women with a common type of breast cancer can forgo chemotherapy and be successfully treated with hormone therapy alone.Investigators from the RxPONDER study found no added benefit of chemotherapy in

    Tweet Tweets with this article
    • #SABCS20 ⁦@OncoAlert⁩ #bcsm Who is excited to see it? How have you been handling 1-3 positive nodes in your practice? Anyone you are omitting chemo for? Postmeno only? Premenopausal? RxPONDER Study Chemotherapy in Postmenopausal Women | BCRF https://t.co/FZ8WA9SEE0

  • Mashup Score: 0

    It takes a village to understand and solve breast cancer. In this case, the village is more like an innovative network of research labs, scientists, patients, funders, and more. In other words, something like the Translational Breast Cancer Research Consortium (TBCRC) led by Dr. Antonio Wolff.

    Tweet Tweets with this article
    • .@awolff from @hopkinskimmel and @JHBreastGyn talks with @BCRFcure about a cross-disciplinary approach to #breast cancer. https://t.co/GdNVb6NIs0

  • Mashup Score: 5

    Metastasis, the spread of cancer cells from the breast to other sites in the body, is responsible for nearly all breast cancer deaths. Approximately 150,000 men and women are diagnosed with metastatic breast cancer each year.

    Tweet Tweets with this article
    • BCRF has a podcast? Of course. In this episode, Dr. Martine Piccart discusses her research into the causes of metastatic breast cancer including the #AURORA project, @BCRFcure - https://t.co/CxLJtMHRjk @BIGagainstBC